To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

Granules India Ltd Fundamentals

info2
Compare peers arrow

Market Cap

11,553.48 Cr.

Face value

1.00

Book value

152.56

Div. yield

0.32%

P/E ratio

23.04

P/B ratio

3.12

Debt/Eq.

0.35

Market Cap

11,553.48 Cr.

Face value

1.00

Book value

152.56

Div. yield

0.32%

P/E ratio

23.04

P/B ratio

3.12

Debt/Eq.

0.35
About Granules India Ltd
arrow

Granules India Limited is one of the vertically integrated, high-growth pharmaceutical manufacturing company in India. Based out of Hyderabad, India, it is into manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Interm Read more ▾

IndustryPharmaceuticals & Drugs
SectorHealthcare
Top subsidiaries
Granules Life Sciences Pvt Ltd.Granules Peptides Pvt Ltd.Granules CZRO Pvt Ltd.Granules USA IncGranules Pharmaceuticals Inc
MANAGEMENT
Non Independent & Non Executive DirectorArun Sawhney
Non Independent & Non Executive DirectorKB Sankar Rao
Non Independent Executive DirectorHarsha Chigurupati
Non Independent Executive DirectorUma Devi Chigurupati
Chairman & Managing DirectorKrishna Prasad Chigurupati
Chairman & Managing DirectorKrishna Prasad Chigurupati
Non Executive Independent DirectorKapil Kumar Mehan
Non Executive Independent DirectorSucharita Rao Palepu
Non Independent & Non Executive DirectorSaumen Chakraborty
Company Secretary & Compliance OfficerChaitanya Tummala
Chairman & Managing DirectorKrishna Prasad Chigurupati
Chairman & Managing DirectorKrishna Prasad Chigurupati
Joint Managing Director & Chief Executive OfficerKandiraju Venkata Sitaram Rao
Executive DirectorUma Devi Chigurupati
Executive DirectorHarsha Chigurupati
Non Executive Independent DirectorArun Rao Akinepally
Non Executive Independent DirectorArun Sawhney
Non Executive Independent DirectorSaumen Chakraborty
Non Executive Independent DirectorSucharita Rao Palepu
Company Secretary & Compliance OfficerChaitanya Tummala
Non Executive Independent DirectorArun Rao Akinepally
Joint Managing Director & CEOKandiraju Venkata Sitaram Rao
Non Independent & Non Executive DirectorKolli Basava Sankar Rao
Chairman & Managing DirectorKrishna Prasad Chigurupati
Chairman & Managing DirectorKrishna Prasad Chigurupati
Joint Managing Director & CEOKandiraju Venkata Sitaram Rao
Whole Time DirectorUma Devi Chigurupati
Whole Time DirectorHarsha Chigurupati
Whole Time DirectorPriyanka Chigurupati
Non Independent & Non Executive DirectorKolli Basava Sankar Rao
Non Executive Independent DirectorArun Sawhney
Non Executive Independent DirectorSaumen Chakraborty
Non Executive Independent DirectorSucharita Rao Palepu
Non Executive Independent DirectorKapil Kumar Mehan
Non Executive Independent DirectorSethurathnam Ravi
Non Executive Independent DirectorRajiv Pritidas Kakodkar
Company Secretary & Compliance OfficerChaitanya Tummala
Non Independent & Non Executive DirectorKB Sankar Rao
Whole Time DirectorPriyanka Chigurupati
Whole Time DirectorHarsha Chigurupati
Whole Time DirectorUma Devi Chigurupati
Chairman & Managing DirectorKrishna Prasad Chigurupati
Chairman & Managing DirectorKrishna Prasad Chigurupati
Company Secretary & Compliance OfficerChaitanya Tummala
Joint Managing Director & Chief Executive OfficerKandiraju Venkata Sitaram Rao
Non Executive Independent DirectorRajiv Pritidas Kakodkar
Non Executive Independent DirectorSethurathnam Ravi
Non Executive Independent DirectorKapil Kumar Mehan
Non Executive Independent DirectorSucharita Rao Palepu
Non Executive Independent DirectorArun Sawhney
Non Executive Independent DirectorSaumen Chakraborty
Other detail of Granules India Ltd
arrow
location
Address2Nd Floor, Block Iii, My Home Hub, Madhapur, Cyberabad ,Hyderabad ,Telangana-500084.
phone
Telephone040-69043500
MORE DETAILS
NSE Code11872
NSE SymbolGRANULES
SeriesEQ
ISININE101D01020
Granules India Limited is one of the vertically integrated, high-growth pharmaceutical manufacturing company in India. Based out of Hyderabad, India, it is into manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediaries (PFIs) and Finished Dosages (FDs). The company’s product-focused, vertically integrated business model has created a leadership position in several generic drugs. It has a strong presence in ‘first line of defence’ products, including Paracetamol, Ibuprofen, Guaifenesin and Metformin.
personal

Grow your wealth with more research recommendations

+91